Ad is loading...
AORT
Price
$26.65
Change
-$0.34 (-1.26%)
Updated
Nov 15 closing price
88 days until earnings call
CRL
Price
$187.74
Change
-$9.16 (-4.65%)
Updated
Nov 15 closing price
87 days until earnings call
Ad is loading...

AORT vs CRL

Header iconAORT vs CRL Comparison
Open Charts AORT vs CRLBanner chart's image
Artivion
Price$26.65
Change-$0.34 (-1.26%)
Volume$164.16K
CapitalizationN/A
Charles River Laboratories International
Price$187.74
Change-$9.16 (-4.65%)
Volume$1.5M
CapitalizationN/A
AORT vs CRL Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AORT vs. CRL commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Sell and CRL is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AORT: $26.65 vs. CRL: $187.74)
Brand notoriety: AORT and CRL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 71% vs. CRL: 199%
Market capitalization -- AORT: $873.56M vs. CRL: $13.96B
AORT [@Medical Specialties] is valued at $873.56M. CRL’s [@Medical Specialties] market capitalization is $13.96B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileCRL’s FA Score has 0 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • CRL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while CRL’s TA Score has 4 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 5 bearish.
  • CRL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AORT is a better buy in the short-term than CRL.

Price Growth

AORT (@Medical Specialties) experienced а -7.18% price change this week, while CRL (@Medical Specialties) price change was -12.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

AORT is expected to report earnings on Feb 13, 2025.

CRL is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than AORT($874M). AORT has higher P/E ratio than CRL: AORT (434.78) vs CRL (29.15). AORT YTD gains are higher at: 49.049 vs. CRL (-20.584). CRL has higher annual earnings (EBITDA): 1.03B vs. AORT (26.8M). CRL has more cash in the bank: 277M vs. AORT (58.9M). AORT has less debt than CRL: AORT (358M) vs CRL (3.07B). CRL has higher revenues than AORT: CRL (4.13B) vs AORT (354M).
AORTCRLAORT / CRL
Capitalization874M14B6%
EBITDA26.8M1.03B3%
Gain YTD49.049-20.584-238%
P/E Ratio434.7829.151,492%
Revenue354M4.13B9%
Total Cash58.9M277M21%
Total Debt358M3.07B12%
FUNDAMENTALS RATINGS
AORT vs CRL: Fundamental Ratings
AORT
CRL
OUTLOOK RATING
1..100
759
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
8476
SMR RATING
1..100
8761
PRICE GROWTH RATING
1..100
4260
P/E GROWTH RATING
1..100
8550
SEASONALITY SCORE
1..100
8534

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (77) in the Miscellaneous Commercial Services industry is in the same range as AORT (94) in the Medical Specialties industry. This means that CRL’s stock grew similarly to AORT’s over the last 12 months.

CRL's Profit vs Risk Rating (76) in the Miscellaneous Commercial Services industry is in the same range as AORT (84) in the Medical Specialties industry. This means that CRL’s stock grew similarly to AORT’s over the last 12 months.

CRL's SMR Rating (61) in the Miscellaneous Commercial Services industry is in the same range as AORT (87) in the Medical Specialties industry. This means that CRL’s stock grew similarly to AORT’s over the last 12 months.

AORT's Price Growth Rating (42) in the Medical Specialties industry is in the same range as CRL (60) in the Miscellaneous Commercial Services industry. This means that AORT’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (50) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AORT (85) in the Medical Specialties industry. This means that CRL’s stock grew somewhat faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTCRL
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 7 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
57%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KGGIX12.050.07
+0.58%
Kopernik Global All-Cap I
HGXYX15.51-0.15
-0.96%
Hartford Global Impact Y
MMQSX9.50-0.11
-1.14%
MassMutual Small Cap Val Eq R5
FZAFX25.76-0.53
-2.02%
Fidelity Advisor Equity Growth Z
DLHAX27.00-0.82
-2.95%
Delaware Healthcare A

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with ESTA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then ESTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-1.26%
ESTA - AORT
42%
Loosely correlated
+0.75%
SONVY - AORT
42%
Loosely correlated
-0.52%
KIDS - AORT
40%
Loosely correlated
+1.06%
ALGN - AORT
39%
Loosely correlated
+0.92%
CRL - AORT
39%
Loosely correlated
-4.65%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-4.65%
IQV - CRL
73%
Closely correlated
-5.06%
CTKB - CRL
62%
Loosely correlated
-7.32%
AZTA - CRL
59%
Loosely correlated
-2.62%
RGEN - CRL
56%
Loosely correlated
-12.43%
TMO - CRL
53%
Loosely correlated
-3.74%
More